Literature DB >> 2014247

Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse.

D R Love1, G E Morris, J M Ellis, U Fairbrother, R F Marsden, J F Bloomfield, Y H Edwards, C P Slater, D J Parry, K E Davies.   

Abstract

We have previously reported a dystrophin-related locus (DMDL for Duchenne muscular dystrophy-like) on human chromosome 6 that maps close to the dy mutation on mouse chromosome 10. Here we show that this gene is expressed in a wide range of tissues at varying levels. The transcript is particularly abundant in several human fetal tissues, including heart, placenta, and intestine. Studies with antisera raised against a DMDL fusion protein identify a 400,000 Mr protein in all mouse tissues tested, including those of mdx and dy mice. Unlike the dystrophin gene, the DMDL gene transcript is not differentially spliced at the 3' end in either fetal muscle or brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014247      PMCID: PMC51422          DOI: 10.1073/pnas.88.8.3243

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Shedding light on PCR contamination.

Authors:  G Sarkar; S S Sommer
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

2.  alpha-Actinins and the DMD protein contain spectrin-like repeats.

Authors:  M D Davison; D R Critchley
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

3.  Immunoelectron microscopic localization of dystrophin in myofibres.

Authors:  S C Watkins; E P Hoffman; H S Slayter; L M Kunkel
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

6.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

7.  Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy.

Authors:  H O Hirzel; C R Tuchschmid; J Schneider; H P Krayenbuehl; M C Schaub
Journal:  Circ Res       Date:  1985-11       Impact factor: 17.367

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.

Authors:  C A Feener; M Koenig; L M Kunkel
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

10.  Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene.

Authors:  T J Smith; S M Forrest; G S Cross; K E Davies
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

View more
  34 in total

1.  A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

Authors:  T R Helliwell; J M Ellis; R C Mountford; R E Appleton; G E Morris
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice.

Authors:  Alison R Amenta; Atilgan Yilmaz; Sasha Bogdanovich; Beth A McKechnie; Mehrdad Abedi; Tejvir S Khurana; Justin R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

4.  Utrophin is lacking at the neuromuscular junctions in the extraocular muscles of normal cat: artefact or true?

Authors:  Maziar Assadi; Markus Müntener
Journal:  Histochem Cell Biol       Date:  2005-02-24       Impact factor: 4.304

5.  2015 William Allan Award.

Authors:  Kay E Davies
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

6.  Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice.

Authors:  D A Williams; S I Head; G S Lynch; D G Stephenson
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

7.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

8.  Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.

Authors:  H Xu; P Christmas; X R Wu; U M Wewer; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.

Authors:  T Voit; K Haas; J O Léger; F Pons; J J Léger
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

10.  Dystrophin-related protein in skeletal muscles in neuromuscular disorders: immunohistochemical study.

Authors:  M Takemitsu; I Nonaka; H Sugita
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.